001     164086
005     20230915090548.0
024 7 _ |a 10.1093/infdis/jiac103
|2 doi
024 7 _ |a pmid:35313340
|2 pmid
024 7 _ |a 0022-1899
|2 ISSN
024 7 _ |a 1537-6613
|2 ISSN
024 7 _ |a altmetric:125146599
|2 altmetric
037 _ _ |a DZNE-2022-00749
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a ToVinh, Michael
|0 0000-0002-1625-9741
|b 0
245 _ _ |a Mitochondrial dysfunction contributes to impaired cytokine production of CD56 bright NK cells from HIV(+) individuals under effective antiviral therapy.
260 _ _ |a Oxford [u.a.]
|c 2022
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1665148524_1935
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a HIV infection is associated with impaired NK cell activity, which is only incompletely restored under antiretroviral therapy. Analysing the bioenergetics profiles of oxygen consumption, we observed several parameters were significantly reduced in HIV(+) NK cells, indicating a mitochondrial defect. Accordingly, we found HIV(+) CD56 bright NK cells to display a decreased mitochondrial membrane potential and mitochondrial mass. Both parameters were positively correlated with IFNγ production of NK cells. Finally, we demonstrated that stimulation of HIV(+) NK cells with MitoTEMPO, mitochondria-targeting antioxidant, significantly improved IFNγ production. In conclusion, we identified mitochondrial dysfunction as a mechanism that contributes to impaired NK cell function.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a HIV
|2 Other
650 _ 7 |a IFNγ
|2 Other
650 _ 7 |a NK cell
|2 Other
650 _ 7 |a immunometabolism
|2 Other
650 _ 7 |a mitochondrial dysfunction
|2 Other
693 _ _ |0 EXP:(DE-2719)IDAF-20190308
|5 EXP:(DE-2719)IDAF-20190308
|e Image and Data Analysis Facility (CRFS-IDAF) / Bonn
|x 0
700 1 _ |a Hörr, Gregor
|b 1
700 1 _ |a Dobrikova, Kristiyana
|b 2
700 1 _ |a Gotter, Christina
|b 3
700 1 _ |a Rommel, Clemens
|b 4
700 1 _ |a Hoffmeister, Christoph
|b 5
700 1 _ |a Raabe, Jan
|b 6
700 1 _ |a Kaiser, Kim M
|b 7
700 1 _ |a Finnemann, Claudia
|b 8
700 1 _ |a Bischoff, Jenny
|0 0000-0002-7700-2915
|b 9
700 1 _ |a Rieke, Gereon J
|b 10
700 1 _ |a Wilhelm, Christoph
|b 11
700 1 _ |a Schmitt, Vanessa
|b 12
700 1 _ |a Möhl, Christoph
|0 P:(DE-2719)2810422
|b 13
|u dzne
700 1 _ |a Aghabeig, Mansoureh
|0 P:(DE-2719)2814300
|b 14
|u dzne
700 1 _ |a Schwarze-Zander, Carolynne
|b 15
700 1 _ |a Boesecke, Christoph
|b 16
700 1 _ |a van Bremen, Kathrin
|b 17
700 1 _ |a Wasmuth, Jan-Christian
|b 18
700 1 _ |a Strassburg, Christian P
|b 19
700 1 _ |a Rockstroh, Jürgen K
|b 20
700 1 _ |a Spengler, Ulrich
|b 21
700 1 _ |a Krämer, Benjamin
|b 22
700 1 _ |a Nattermann, Jacob
|b 23
773 _ _ |a 10.1093/infdis/jiac103
|g p. jiac103
|0 PERI:(DE-600)1473843-0
|n 5
|p 901-906
|t The journal of infectious diseases
|v 226
|y 2022
|x 0022-1899
909 C O |p VDB
|o oai:pub.dzne.de:164086
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 13
|6 P:(DE-2719)2810422
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2814300
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-03
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2022-11-25
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J INFECT DIS : 2021
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-25
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-25
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J INFECT DIS : 2021
|d 2022-11-25
920 1 _ |0 I:(DE-2719)1040200
|k IDAF
|l Image and Data Analysis (IDAF)
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1040200
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21